Literature DB >> 7499903

Does it matter how coronary projections are combined to assess restenosis following PTCA?

B C Morton1, J B Gill, R S Roberts, B G Larocque, L A Jozwiak, J A Cairns.   

Abstract

Three methods were used to combine measurements from biplane coronary views to assess restenosis following PTCA. The first 153 patients from the EMPAR trial with 118 measurable coronary stenoses were chosen for this study. The mean difference between the RAO and LAO projections used was 88 +/- 22 degrees (S.D.). There was no systematic difference in coronary dimensions between RAO and LAO views for the group. Coronary restenosis was primarily defined as loss of 50% or more of the luminal diameter gain from the procedure. The ratio of luminal loss to gain was calculated for each stenosis using (Method 1) only the lesser diameter of the two views, (Method 2) an average of the two views and, (Method 3) a calculated cross-sectional coronary lumen area. Rates of restenosis calculated in this way ranged between 36 and 44% amongst the three methods, which was not significantly different. However, individual coronary lesions might be classified as either restenosed or not by this formula, depending on which method was used to integrate the biplane coronary measurements.

Entities:  

Mesh:

Year:  1995        PMID: 7499903     DOI: 10.1007/bf01143103

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  10 in total

1.  Comparison by quantitative angiographic assessment of coronary stenoses of one view showing the severest narrowing to two orthogonal views.

Authors:  J Lesperance; G Hudon; C W White; J Laurier; D Waters
Journal:  Am J Cardiol       Date:  1989-09-01       Impact factor: 2.778

2.  Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.

Authors:  L Schwartz; M G Bourassa; J Lespérance; H E Aldridge; F Kazim; V A Salvatori; M Henderson; R Bonan; P R David
Journal:  N Engl J Med       Date:  1988-06-30       Impact factor: 91.245

3.  Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.

Authors:  P W Serruys; H E Luijten; K J Beatt; R Geuskens; P J de Feyter; M van den Brand; J H Reiber; H J ten Katen; G A van Es; P G Hugenholtz
Journal:  Circulation       Date:  1988-02       Impact factor: 29.690

Review 4.  Defining coronary restenosis. Newer clinical and angiographic paradigms.

Authors:  R E Kuntz; D S Baim
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

5.  Assessment of stenoses in coronary angioplasty. Inter- and intraobserver variability.

Authors:  B Meier; A R Gruentzig; N Goebel; R Pyle; W von Gosslar; M Schlumpf
Journal:  Int J Cardiol       Date:  1983-05       Impact factor: 4.164

6.  Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution: a quantitative angiographic study in 1,445 successfully dilated lesions.

Authors:  B J Rensing; W R Hermans; J W Deckers; P J de Feyter; J G Tijssen; P W Serruys
Journal:  J Am Coll Cardiol       Date:  1992-04       Impact factor: 24.094

7.  Restenosis after coronary angioplasty: new standards for clinical studies.

Authors:  K J Beatt; P W Serruys; P G Hugenholtz
Journal:  J Am Coll Cardiol       Date:  1990-02       Impact factor: 24.094

8.  Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.

Authors:  M A Thornton; A R Gruentzig; J Hollman; S B King; J S Douglas
Journal:  Circulation       Date:  1984-04       Impact factor: 29.690

9.  Restenosis after coronary angioplasty: the paradox of increased lumen diameter and restenosis.

Authors:  K J Beatt; P W Serruys; H E Luijten; B J Rensing; H Suryapranata; P de Feyter; M van den Brand; G J Laarman; J Roelandt
Journal:  J Am Coll Cardiol       Date:  1992-02       Impact factor: 24.094

10.  Percutaneous transluminal coronary angioplasty and subsequent restenosis: quantitative and qualitative methodology for their assessment.

Authors:  B G Brown; E L Bolson; H T Dodge
Journal:  Am J Cardiol       Date:  1987-07-31       Impact factor: 2.778

  10 in total
  2 in total

1.  Establishing an approach for patients with recent coronary occlusion: identification of viable myocardium.

Authors:  R S Beanlands; M Labinaz; T D Ruddy; J F Marquis; W Williams; M LeMay; L A Laramee; E O'Brien; S A Kearns; M Aung; H Johansen; L A Higginson
Journal:  J Nucl Cardiol       Date:  1999 May-Jun       Impact factor: 5.952

2.  Stress perfusion/metabolism imaging: a pilot study for a potential new approach to the diagnosis of coronary disease in women.

Authors:  B L Abramson; T D Ruddy; R A deKemp; L A Laramee; J F Marquis; R S Beanlands
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.